1. Home
  2. FUBO vs ASMB Comparison

FUBO vs ASMB Comparison

Compare FUBO & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo fuboTV Inc.

FUBO

fuboTV Inc.

HOLD

Current Price

$1.18

Market Cap

409.1M

Sector

Industrials

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$28.57

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUBO
ASMB
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
409.1M
440.0M
IPO Year
2011
2010

Fundamental Metrics

Financial Performance
Metric
FUBO
ASMB
Price
$1.18
$28.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$3.98
$43.40
AVG Volume (30 Days)
15.7M
91.6K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
48.08
50.00
EPS
N/A
N/A
Revenue
$4,271,000.00
N/A
Revenue This Year
$24.29
$33.33
Revenue Next Year
$26.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10317.07
N/A
52 Week Low
$1.11
$7.76
52 Week High
$4.72
$39.71

Technical Indicators

Market Signals
Indicator
FUBO
ASMB
Relative Strength Index (RSI) 22.20 49.61
Support Level N/A $26.50
Resistance Level $2.79 $31.11
Average True Range (ATR) 0.07 1.84
MACD 0.04 0.11
Stochastic Oscillator 26.00 57.55

Price Performance

Historical Comparison
FUBO
ASMB

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: